| Axis
Genetics plc is a private company based in Cambridge, UK, developing vaccines from
plants. The company is working with the Boyce
Thompson Institute for Plant Research, Ithaca, New York, to develop Edible Plant
Vaccines for the prevention of hepatitis B, enterotoxigenic E. coli travellers' diarrhoea,
and Norwalk virus infections. Using its proprietary chimaeric virus particle technology
EPICOAT, Axis is developing vaccines for cancer, Pseudomonas aeruginosa and Staphylococcus
aureus infections. |
